Goodman Co., Ltd. – Trademark Portfolio

Entity Type: 03

Goodman Co., Ltd. holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 19 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 14 trademarks are registered and 3 are pending. Notable registered marks include A, GM-30, N S E, VECTRA, and O'SHUNTÉ.

5th Floor, KDX Nagoya Sakae Building

4-5-3 Sakae, Naka-ku, Nagoya-shi, Alchi

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Goodman Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (19 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Goodman Co., Ltd. have?

Goodman Co., Ltd. has 20 U.S. trademarks filed with the USPTO. Of these, 14 registered, 3 pending, 1 abandoned, 1 cancelled.

What trademark classes does Goodman Co., Ltd. file in?

Goodman Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Goodman Co., Ltd.'s most well-known trademarks?

Goodman Co., Ltd.'s registered trademark portfolio includes well-known marks such as A, GM-30, N S E, VECTRA, and O'SHUNTÉ. These are among 14 currently registered trademarks in the portfolio.

What is Goodman Co., Ltd.'s trademark registration success rate?

Goodman Co., Ltd. has a 88% trademark registration rate, with 14 out of 16 resolved applications resulting in successful registration. Currently, 3 applications are pending review.